Faron, etusivu

releases and announcements

Holding(s) in Company

Shareholder announcement Regulatory

Clevegen successful toxicity studies

Regulatory

Holdings in Company

Shareholder announcement Regulatory

Director/PDMR Shareholding

Insider Transaction Regulatory

Director/PDMR Shareholding

Insider Transaction Regulatory

Holding(s) in Company

Shareholder announcement Regulatory

Holdings in Company

Shareholder announcement Regulatory

Biomarker analysis of Phase III INTEREST trial

Regulatory

Result of AGM

Regulatory

AGM Statement

Regulatory
PreviousNext
Back to top